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ABSTRACT
Objective To examine the duration and magnitude of
increased risk of venous thromboembolism after different
types of surgery.
Design Prospective cohort study (Million Women Study).
SettingQuestionnaire data from theMillionWomenStudy
linked with hospital admission and death records.
Participants 947454 middle aged women in the United
Kingdom recruited in 1996-2001 and followed by record
linkage to routinely collected NHS data on hospital
admissions and deaths. During follow-up 239614
admissionswere for surgery; 5419womenwere admitted,
and a further 270 died, from venous thromboembolism.
Main outcome measures Adjusted relative risks and
standardised incidence rates for hospital admission or
death from venous thromboembolism (pulmonary
embolism or deep vein thrombosis), by time since and
type of surgery.
Results Compared with not having surgery, women were
70 times more likely to be admitted with venous
thromboembolism in the first six weeks after an inpatient
operation (relative risk 69.1, 95% confidence interval
63.1 to 75.6) and 10 times more likely after a day case
operation (9.6, 8.0 to 11.5). The risks were lower but still
substantially increased 7-12 weeks after surgery (19.6,
16.6 to 23.1 and5.5, 4.3 to 7.0, respectively). This pattern
of risk was similar for pulmonary embolism (n=2487) and
deep venous thrombosis (n=3529). The postoperative
risks of venous thromboembolism varied considerably by
surgery type, with highest relative risks after inpatient
surgery for hip or knee replacement and for cancer—
1-6 weeks after surgery the relative risks were,
respectively, 220.6 (187.8 to 259.2) and 91.6 (73.9 to
113.4).
Conclusion The risk of deep vein thrombosis and
pulmonary embolism after surgery is substantially
increased in the first 12 postoperative weeks, and varies
considerably by type of surgery. An estimated 1 in 140
middle aged women undergoing inpatient surgery in the
UK will be admitted with venous thromboembolism
during the 12weeks after surgery (1 in 45 after hip or knee
replacement and 1 in 85 after surgery for cancer),
compared with 1 in 815 after day case surgery and only 1
in 6200 women during a 12 week period without surgery.
INTRODUCTION
Pulmonary embolism and its precursor deep vein
thrombosis (collectively termed venous thromboem-
bolism here) are associated with a significant burden
of morbidity and mortality worldwide.1 The highest
risk of postoperative venous thromboembolism is dur-
ing the first few weeks after surgery,2-4 but the exact
pattern and magnitude of this increased risk over
time is uncertain. Although the risk may vary accord-
ing to indication for or type of surgery,5 with particu-
larly high risks in patients with cancer6-8 and those
undergoing major orthopaedic surgery,9-11 the magni-
tude and duration of risk associated with different indi-
cations for surgery is unknown. Using hospital records
on admissions and death records linked with question-
naire data from a large cohort of UK women, the Mil-
lionWomen Study, we examined the pattern of risk of
venous thromboembolism over time since surgery and
by surgery type.
METHODS
The Million Women Study is a population based pro-
spective study that recruited 1.3 million women (mean
age 56) through the National Health Service (NHS)
breast screening programme between 1996 and 2001.
The recruitment questionnaire (see www.million
womenstudy.org) asked about various lifestyle and
personal characteristics, and participants gave written
consent for inclusion and follow-up.
Both England and Scotland have central databases
on NHS funded hospital admissions (the hospital epi-
sode statistics12 for England and the Scottishmorbidity
records13 for Scotland), with individually linked data
available from1997 in England and from 1981 in Scot-
land. Participants in the Million Women Study were
electronically linked to their inpatient and day case
NHS hospital admission records in these databases
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using NHS number (a unique personal identifier used
for all NHShealth records), date of birth, sex, and fore-
names and surnames, and were similarly linked to the
NHS central registers for follow-up on deaths, cancer
registrations, and emigrations.14
Each hospital admission record has coded data on
the primary diagnosis and up to 13 other diagnoses
(coded using the ICD-10, international classification
of diseases, 10th revision), as well as for up to 12 pro-
cedures (codedusing theOPCS-4,Office of Population
Censuses and Surveys classification of surgical opera-
tions and procedures, fourth revision15). The exposure
of interest for these analyses was an inpatient or day
case hospital admission for a surgical procedure. The
main outcomes were the first diagnosis of pulmonary
embolism (ICD-10 code I26) or deep vein thrombosis
(I80-I82) as an inpatient or day case hospital admission
(principal diagnosis or comorbidity) or as an underly-
ing cause of death.
Statistical analysis
We excluded 207 302 women from the analyses who
had a hospital admission for venous thromboembo-
lism before recruitment or reported a history of blood
clot or treatment for clotting problems at recruitment,
orwhohadprevious cancer orwhohad an operation in
the year before the start of follow-up. We excluded a
further 208 538 women with more than one operation
during follow-up so that the risk after a single admis-
sion for surgery could be examined, thus minimising
any confounding from multiple operations.
We calculated person years from the date of recruit-
ment to whichever came first of the date of first hospital
admission for venous thromboembolism, date of death
(with or without a diagnosis of venous thromboembo-
lism), date of emigration, or end of follow-up for hospi-
tal admissions, after which the hospital administration
data were incomplete—for women recruited in Scot-
land this final date of follow-up was 31 December
2003, whereas for those recruited in England it was
31 March 2005. A small proportion of women in Eng-
land (5%) were recruited before 1 April 1997 and we
calculated person years from this date for such women.
We took the person years before any operation as
the reference period,whichwe refer to as “no surgery.”
This includes all person years of follow-up for women
with no operations during the entire follow-up period
as well as the person years before their operation for
womenwith an operation after recruitment.We exam-
ined day case and inpatient operations separately—
inpatient operations were defined as those requiring
an overnight stay in hospital and day case operations
as those where women were admitted and discharged
on the same day.
We usedCox regressionmodels with attained age as
the underlying time variable to estimate the relative
risk of venous thromboembolism in relation to time
since surgery and surgery type. These exposure vari-
ables were fitted as time dependent covariates, so that
all women initially contributed person years to the
reference period (no surgery), then those with an
operation moved through categories representing var-
ious time periods after their surgery during follow-up.
We routinely stratified analyses by area of recruitment
(10 geographical regions) and socioeconomic status,
defined in fifths using the Townsend method.16 Addi-
tional adjustment was made for bodymass index (<25,
25-29, ≥30 kg/m2) and use of hormone replacement
therapy at recruitment (never, past, current). Other
potential confounders, such as use of oral contracep-
tives, smoking status, and alcohol consumption, and
conditions such as acute myocardial infarction, heart
failure, inflammatory bowel disease, respiratory fail-
ure, stroke, or varicose veins, were investigated as
adjustment factors in the models, but as they had little
additional effect on the relative risks estimates they
were not retained as adjustment factors. We included
women with missing values for any of the baseline
characteristic variables in a separate category for that
variable.
For the initial analyses we divided the first year after
surgery into weekly periods for the first 12 weeks then
monthly (in 31 day periods) up to one year, and we
examined the relative risk of venous thromboembo-
lism during each of these periods after surgery com-
pared with the risk with no surgery. We then
amalgamated these categories, based on the pattern
of risk observed in our detailed analyses, into three
time periods for the first postoperative year: weeks 1-
6, weeks 7-12, andmonths 4-12.Cancer is a known risk
factor for venous thromboembolism and a common
reason for surgery, so when we examined the relative
risks after different types of surgery, we classified
operation records with a cancer code (ICD-10 codes
beginning with “C”) as cancer surgery, and women
without such a record were classified by OPCS-4
codes as: orthopaedic (all OPCS-4 codes beginning
with “W”), vascular (all “K” and “L” codes), gynaeco-
logical (all “Q” codes), gastrointestinal (all “G” and
“H” codes), and all other surgery. Because of the
knownassociation betweenvenous thromboembolism
and major orthopaedic surgery, we subdivided the
orthopaedic operations into hip, knee, or femoral
head replacements (specifically codes W37-W42,
W46-W48), fracture surgery (codes W19-W26), and
all other types of orthopaedic surgery (remaining
“W” codes). For the few cases (<0.5% of all operation
episodes) with more than one operation code on the
same hospital record, we applied a hierarchy in the
following order for classifying the overall operation:
cancer, hip or knee replacement, fracture, other ortho-
paedic operations, and vascular, gynaecological,
gastrointestinal, and all other surgery.
We calculated standardised incidence rates for hos-
pital admission or death from venous thromboembo-
lism using incidence rates without surgery as the
standard and standardising for region, socioeconomic
group, body mass index, and use of hormone replace-
ment therapy. Relative risks are reported with 95%
confidence intervals; all analyses were done using
Stata 10.1 software.
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RESULTS
Overall, 947 454 women were included in the main
analyses, and participants were followed for a total of
5.84million person years (mean 6.2 years per woman),
during which time 239 614 women (25%) had an
operation (149 355 as a day case and 90 259 as an inpa-
tient). Table 1 shows characteristics of the study popu-
lation according to whether or not they had an
operation during follow-up. The two groups were
broadly similar for baseline characteristics, except
that women who had an operation after recruitment
were slightly more likely to have been current users
of hormone replacement therapy.
During follow-up 5419 women were admitted to
hospital with pulmonary embolism or deep vein
thrombosis and 270 had a first diagnosis of venous
thromboembolism at death. These 5689 women
(0.6% of the study population) are described here as
having a first venous thromboembolic event, regard-
less of whether it was a hospital admission or a death.
Table 2 shows the distribution of venous throm-
boembolism events by time since surgery. More than
one third of all such events in this population were
diagnosed among the 25% of womenwho had surgery,
with 16% of all cases diagnosed in the 12 weeks after
surgery (3% after day case surgery, 13% after inpatient
surgery). In contrast, only 1% of the total person years
occurred in the 12 weeks after surgery.
Relative risks over time since surgery
The relative risk of venous thromboembolism after sur-
gery varied considerably by time since surgery, particu-
larly after an inpatient operation (fig 1). Compared with
incidence rates without surgery, women were 40 times
more likely to develop venous thromboembolism dur-
ing the week after an inpatient operation (relative risk
40.3, 30.7 to52.8), rising to110 timesmore likelyduring
the third postoperative week (112.5, 95.3 to 132.8). The
risk thendecreased, but remained substantially elevated
up to 12weeks postoperatively. The overall relative risk
was 69.1 (63.1 to 75.6) for the first six weeks after sur-
gery, 19.6 (16.6 to 23.1) 7-12weeks postoperatively, 9.4
(8.0 to 11.1) 4-6 months postoperatively, 6.1 (5.0 to 7.5)
7-9 months postoperatively, and 3.7 (2.8 to 4.9)
10-12 months postoperatively.
After day case surgery the relative risks of venous
thromboembolismwere lower than after inpatient sur-
gerybut still significantly increased, at almost 10 for the
first six weeks after surgery (9.6, 8.0 to 11.5) and about
six for 7-12 weeks after surgery (5.5, 4.3 to 7.0). The
relative risks after day case surgery were still slightly
increased afterwards, at 3.7 (3.0 to 4.5) 4-6 months
after surgery, 2.6 (2.0 to 3.3) 7-9 months after surgery,
and 2.6 (2.0 to 3.4) 10-12 months after surgery.
The overall patterns of relative risk were similar in
analyses taking pulmonary embolism and deep vein
thrombosis as separate outcomes (fig 2).
Table 1 | Characteristics at recruitment of women with and without an operation during follow-up. Values are percentages
unless stated otherwise
Characteristics
Operation during follow-up
All womenNo Yes
No of women 707 840 239 614 947 454
Baseline:
Mean (SD) age (years) 55.8 (4.6) 56.1 (4.7) 55.8 (4.6)
Mean (SD) body mass index (weight (kg)/(height)m2) 25.9 (4.5) 26.3 (4.7) 26.0 (4.6)
Current user of hormone replacement therapy 31.2 35.9 32.4
Ever user of oral contraceptives 59.6 58.9 59.4
Mean (SD) alcohol intake among drinkers (g/day) 8.4 (7.8) 8.0 (7.6) 8.3 (7.8)
Lowest socioeconomic fifth 18.1 20.2 18.6
Strenuous physical activity more than once a week 22.2 20.5 21.8
Postmenopausal 84.6 85.9 84.9
Mean (SD) No of children 2.1 (1.2) 2.2 (1.2) 2.1 (1.2)
Current smoker 19.8 20.5 20.0
Follow-up:
Person years of follow-up 4 343 876 1 491 458 5 835 334
No (%) of women with incident venous thromboembolism during follow-up 3589 (0.5) 2100 (0.9) 5689 (0.6)
Estimates for each variable were calculated in women with no missing values.
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Fig 1 | Relative risk of venous thromboembolism by time since inpatient surgery and since day
case surgery
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Indications for surgery
The postoperative risks of venous thromboembolism
were investigated according to indication for or type of
surgery. The median lengths of (inpatient) hospital stay
were five days after cancer surgery, eight days after hip
or knee replacement, three days after fracture surgery,
two days after other orthopaedic surgery, two days after
vascular surgery, four days after gynaecological sur-
gery, four days after gastrointestinal surgery, and two
days after all other surgery. Figure 3 gives the relative
risks after inpatient surgery and figure 4 gives the corre-
sponding relative risks after day case surgery. In the six
weeks after inpatient surgery the greatest relative risk
was that associated with joint replacement, at more
than 200 times the risk without surgery: relative risk
220.6 (95% confidence interval 187.8 to 259.2). The
relative risks after surgery for cancer, fracture, and vas-
cular conditions were also substantially increased: 91.6
(73.9 to 113.4), 89.0 (65.5 to 121.0), and 87.0 (67.2 to
112.5), respectively. The relative risks associated with
other orthopaedic and gastrointestinal surgery were
also high: 57.3 (42.3 to 77.7) and 56.3 (39.4 to 80.4),
respectively.The risk of venous thromboembolismdur-
ing the six weeks after inpatient surgery for gynaecolo-
gical and all other indications was still more than 20
times that associated with no surgery: 22.7 (14.8 to
34.9) and 36.0 (29.6 to 43.8), respectively.
The highest relative risk for postoperative weeks
7-12 was after inpatient surgery for cancer (53.4, 40.0
to 71.4). The relative risks after major joint
replacement and fracture surgery decreased rapidly
from those in the first six weeks to: 39.7 (27.3 to 57.8)
and 39.8 (25.0 to 63.4), respectively. The relative risks
after inpatient surgery for vascular, gastrointestinal,
and gynaecological conditions were all increased
more than 10-fold (15.8 (8.5 to 29.3), 18.5 (9.9 to
34.6), and 11.1 (5.9 to 20.6), respectively), and the rela-
tive risk after other orthopaedic surgery and all other
inpatient surgery were still more than five times that
without surgery (5.6, 2.1 to 14.9 and 8.4, 5.6 to 12.6,
respectively).
The increased relative risk associated with inpatient
surgery for cancer was still evident 4-12 months after
surgery (34.4, 29.3 to 40.2) and one year or more after
surgery (6.1, 4.9 to 7.6). The overall relative risk after
inpatient surgery for non-cancer conditions was 3.3
(2.8 to 3.9) 4-12 months after surgery and 1.7 (1.5 to
1.9) one year or more after surgery.
Few operations for joint replacement or fracture
were done as day cases so the risks associated with
these procedures could not be estimated. Cancer
dominated the findings for day case surgery (fig 4),
with relative risks of 80.4 (54.0 to 119.6) for the six
weeks after surgery, 47.7 (28.6 to 79.6) for the
7-12 weeks after surgery, and 12.1 (7.9 to 18.7) for the
4-12 months after surgery. Relative risks were more
than 20 during the first six weeks after day case vascu-
lar surgery andother orthopaedic surgery (26.4, 17.2 to
40.6 and 22.9, 14.4 to 36.5), and more than doubled
after other types of day case surgery: 2.5 (1.0 to 6.8)
after gynaecological surgery, 5.3 (3.5 to 8.1) after
gastrointestinal surgery, and 6.2 (4.3 to 8.9) after
other surgery.
Results for the separate outcomes of pulmonary
embolism and deep vein thrombosis showed similar
overall patterns in relation to operation type to the
main venous thromboembolism analyses, although
confidence intervals werewider owing to smaller num-
bers in each category (data not shown).
Event rates
The incidence rates are calculated using both hospital
admissions and death records for venous thrombo-
embolism. The incidence rate for venous thromboem-
bolism during all time without surgery was 0.7 per
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Fig 2 | Relative risks of pulmonary embolism and deep vein thrombosis by time since inpatient
surgery
Table 2 | Person years and number of women with incident venous thromboembolism, by time since surgery. Values are
numbers (percentages) unless stated otherwise
Time since surgery Person years (%)
Diagnosis on hospital admission or death record
Deep vein thrombosis or
pulmonary embolism* Deep vein thrombosis† Pulmonary embolism‡
No surgery 5 136 506 (88) 3589 (63) 2248 (64) 1547 (62)
1-6 weeks after surgery 27 187 (0.5) 675 (12) 377 (11) 340 (14)
7-12 weeks after surgery 26 363 (0.5) 218 (4) 145 (4) 86 (3)
4-12 months after surgery 159 153 (3) 520 (9) 337 (10) 210 (8)
≥1 year after surgery 486 126 (8) 687 (12) 422 (12) 304 (12)
Numbers do not add up to total number of women with venous thromboembolism, and corresponding person years also varies slightly because
women are censored at different times in each analysis and some women have had admissions for both conditions.
*Women with pulmonary embolism or deep vein thrombosis.
†Women with pulmonary embolism.
‡Women with deep vein thrombosis.
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1000 person years, which is equivalent to 0.058 per
1000 person months. Corresponding standardised
incidence rates were 2.6 per 1000 personmonths in the
12 weeks after inpatient surgery, 0.4 per 1000 person
months in the 4-12 months after inpatient surgery, and
0.1 per 1000 person months after one year or more,
compared with 0.4, 0.2, and 0.09 per 1000 person
months, respectively, after day case surgery. These
higher rates in the 12 weeks after surgery varied con-
siderably by indication for surgery or surgery type
(table 3): after inpatient surgery the highest rates
were 4.3 per 1000 person months for cancer, 7.7 per
1000 person months for hip or knee replacement, and
3.8 per 1000 person months for fracture surgery, fol-
lowed by 3.1 per 1000 personmonths for vascular sur-
gery and 2.2 per 1000 person months for
gastrointestinal surgery, whereas all other types of
non-cancer inpatient surgery were associated with
rates of less than 2 per 1000 person months; after day
case surgery the rate for cancer surgery was 3.7 per
1000 person months, and for other types of surgery
was less than 1 per 1000 person months.
Over a 12 week period without surgery about 1 in
6200middle agedwomen in theUKwill be admitted to
hospital for, or die from, venous thromboembolism
compared with 1 in 815 during the 12 weeks after a
day case operation, and 1 in 140 women after an inpa-
tient operation.
DISCUSSION
In this large prospective study of middle aged women
in the UK, the risk of hospital admission for, or death
from, venous thromboembolism varied considerably
during the year after an operation. The riskwas highest
during the first six weeks after inpatient surgery, reach-
ing a peak in the third postoperative week. Incidence
rates for venous thromboembolism in the first six post-
operative weeks were over 100 times the rates without
surgery, and 7-12 weeks after inpatient surgery rates
were still almost 20 times higher than without surgery.
The relative risks after day case surgery were lower
than for inpatient surgery but still substantially
increased. The risk of postoperative venous throm-
boembolismalso varied by type of surgery, being high-
est in the six weeks after hip or knee replacement
surgery and in the six weeks after surgery for cancer.
These findings suggest that the risk of venous throm-
boembolism after surgery is greater and lasts for longer
than previously thought. To our knowledge no other
study has looked at the risks of venous thromboembo-
lism in such fine time periods after different types of
surgery. One previous report suggested that the risk
of venous thromboembolism in the six months after
surgery was nine times higher than without surgery,4
another reported a 22-fold increased risk in the
90 days after surgery,17 and another study reported
that the risk of pulmonary embolism was increased in
the second postoperative week, returning to a similar
risk to the first postoperative week one month after
surgery.2 Although one study4 reported a small (10%)
increased risk of venous thromboembolism six or
more months after surgery, most studies simply
reported the mean or median time to venous throm-
boembolism aftermajor surgery, generally after ortho-
paedic surgery.18 19 Overall, we found increased
relative risks of venous thromboembolism during the
12 postoperative weeks that were much larger than
those reported previously.
The recentNational Institute forHealth andClinical
Excellence (NICE) guidelines for the prevention of
venous thromboembolism specified inpatient
surgery9 only. Few studies have directly compared
the risks of venous thromboembolism after day case
and inpatient surgery,20 and although some examined
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Fig 3 | Relative risk of venous thromboembolism by time since inpatient surgery and by surgery
type. Relative risks are adjusted by age, region, socioeconomic status, body mass index, and
use of hormone replacement therapy
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the risk after day surgery alone,21 22 most analyses were
restricted to events occurring within the first two
months. Although we found that the risks of venous
thromboembolism after inpatient surgery were much
higher than after day case surgery, the risks were still
eight times higher in the 12 weeks after a day case
operation than without surgery.
Major orthopaedic surgery—generally of the lower
limb (hip and knee replacements and surgery for hip
fracture) where deep vein thromboses tend to occur—
has been associated with very high risks of postopera-
tive venous thromboembolism.2181923 Most women
undergoing hip or knee replacement or fracture surgery
were admitted as inpatients, and we found that during
the first six weeks after these operations the risks were
increased some 200-fold and 90-fold, respectively, and
other inpatient orthopaedic operations were increased
about 60-fold. The relative risks after inpatient surgery
for hip or knee replacement and fracturewere still about
40 in the 7-12 weeks after surgery. In the recent NICE
guidelines for prevention of venous thromboembolism
in surgical inpatients,9 the recommendation for
extended drug prophylaxis (for up to four weeks after
surgery) for inpatients after surgery for hip fracture, or
hip replacement was only if there was at least one other
predisposing factor. Similarly, the Scottish guidelines10
(from2002) recommenddrug prophylaxis extending to
four or five weeks after orthopaedic surgery only for
high risk patients after hip or knee replacement.
Although women undergoing major orthopaedic sur-
gery are more likely than others to have been given
some thromboprophylaxis after hospital discharge, the
very high incidence of venous thromboembolism after
orthopaedic operations remains.
The strong association between cancer and venous
thromboembolism is known,68 24 and the relative risks
associated with cancer surgery were substantially
higher than those associated with most other indica-
tions for surgery. The increased relative risk that per-
sisted for a year or longer found heremay be due to the
underlying cancer itself rather than to a longlasting
effect of the surgery itself.
Strengths and limitations of the study
We excluded from the analyses all women who
reported being treated for clotting problems, but we
had no information on perioperative prophylactic
measures, such as compression stockings or drugs.
The use of such prophylactic measures would be
expected to vary by type of surgery and possibly also
between hospitals. The characteristics of the patient,
including coexisting risk factors for venous throm-
boembolism, are also likely to influence the prophylac-
tic measures given, and the prophylaxis itself would be
expected to affect the timing of any postoperative
venous thromboembolism. Some of these factors
such as body mass index and use of hormone replace-
ment therapy have been taken into account by adjust-
ments for baseline characteristics, but information on
other risk factors, such as immobility, is lacking.
Although we have no way of knowing exactly what
regimens of prophylaxis these women received, there
are many national and international guidelines for the
prevention of venous thromboembolism9-11 and it is
likely that most women undergoing major surgery
received some form of prophylaxis,25-27 at least until
hospital discharge. Those undergoing procedures
within a day case admission were probably less likely
to receive prophylaxis. NICE9 suggests mechanical
prophylaxis (compression stockings) for all inpatients
having surgery, plus the offer of low molecular weight
heparin (or fondaparinux) for those with an additional
risk factor and those undergoing major orthopaedic
surgery, when prophylaxis may be considered for up
to four weeks. Consequently, the magnitude of the
increased relative risks of venous thromboembolism
after inpatient surgery seen here might have been
higher still in the absence of prophylaxis, particularly
during the first few postoperative weeks.
Since we classified any operative procedure as sur-
gery here28 minor procedures, such as biopsies, were
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Fig 4 | Relative risk of venous thromboembolism by time since day case surgery and by surgery
type. Relative risks are adjusted by age, region, socioeconomic status, body mass index, and
use of hormone replacement therapy. *Joint replacements after day case fracture surgery were
insufficient to estimate relative risks
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included. To avoid any effect ofmultiple operations on
our estimates of the risk of venous thromboembolism
after surgery, we excluded all women with more than
one operation during follow-up. The risks associated
with repeated operations may well be different from
those reported here, particularly as those withmultiple
operations may be more likely to have increased
immobility and other factors affecting their risk of
venous thromboembolism owing to the severity of
their underlying conditions.
Hospital admissions for venous thromboembolism
occurring outside of the NHS in England and Scotland
would not be included in this dataset; however, pri-
vately funded admissions are relatively rare in the
UK2930 and we have previously shown good agree-
ment between self reported operations and NHS hos-
pital admission data.31 In addition, if the index
operation was carried out in an NHS hospital, it is
likely that any subsequent admission for venous
thromboembolism would also be in an NHS hospital;
consequently it is unlikely that many postoperative
venous thromboembolic events have been missed.
Although the diagnosis of pulmonary embolism can
be difficult,32 the severity of this condition means that
most cases will be treated as an inpatient or day case
hospital admission (or result in death). Therefore
symptomatic or fatal pulmonary embolism should
rarely go undetected in this study population. In con-
trast, increasing numbers of cases of deep vein throm-
boses occurring in the general population are treated in
a community setting (general practice) or in outpatient
setting, leading to underestimation of the total inci-
dence of deep vein thrombosis after surgery if based
on hospital admissions alone. Also, women with deep
vein thrombosis may be more likely to be admitted as
an inpatient or day case if they have other predisposing
factors, including recent surgery or certain medical
conditions, such as cancer. The patterns of risk after
surgery were, however, similar for pulmonary embo-
lism and for deep vein thrombosis when each was
examined separately (fig 2). Because we have no infor-
mation on non-fatal venous thromboembolism
(mainly deep vein thrombosis) occurring outside of
the inpatient or day case hospital admissions, our esti-
mates of incidence rates of venous thromboembolism
are for inpatient and day case admissions only.
This study has several strengths. Although venous
thromboembolism is relatively rare in the general
population (0.6% of these participants in the Million
Women Study experienced a venous thromboembo-
lism event during an average of 6.2 person years of
follow-up), the large sample size allowed a detailed
investigation into the magnitude and duration of
increased risk over time since surgery. Access to infor-
mation on a wide range of potential confounders was
used as adjustment factors. The accuracy of the linkage
process and the recording of operations and pulmon-
ary embolism have also been shown to be good.13 28 31
The prospective design of the study, with record link-
age to NHS hospital admissions and cancer and death
records, virtually complete follow-up, and objective
recording both of operations and of venous throm-
boembolism, should provide reliable estimates of risk.
Implications for practice
The incidence of venous thromboembolism after sur-
gery is high for middle aged women. Recommenda-
tions for thromboprophylaxis vary, and the recent
Table 3 | Estimated incidence rates of hospital admission or death for venous thromboembolism among middle aged women
(50-64 years)
Indication for surgery and
type of surgery
Inpatient surgery Day case surgery
Incidence rate per 1000
person months
No who develop VTE over
12 weeks
Incidence rate per 1000
person months
No who develop VTE over
12 weeks
No surgery 0.058* 1 in 6200 0.058* 1 in 6200
After surgery†: 2.61 1 in 140 0.44 1 in 815
Cancer surgery 4.27 1 in 85 3.73 1 in 95
Hip or knee replacement 7.74 1 in 45 Insufficient data Insufficient data
Fracture 3.78 1 in 95 Insufficient data Insufficient data
Other orthopaedic surgery 1.87 1 in 195 0.84 1 in 430
Vascular surgery 3.07 1 in 115 0.93 1 in 390
Gynaecological surgery 0.99 1 in 365 0.20 1 in 1765
Gastrointestinal surgery 2.19 1 in 165 0.29 1 in 1255
Other surgery 1.30 1 in 275 0.30 1 in 1210
VTE=venous thromboembolism.
*Equal to 0.70 per 1000 person years.
†Incidence rates are averages over the first 12 postoperative weeks.
WHAT IS ALREADY KNOWN ON THIS TOPIC
It is well known that the risk of venous thromboembolism is increased after surgery
Information on how long this risk lasts or how the risk varies by type of surgery is, however,
limited
WHAT THIS STUDY ADDS
The postoperative risk of venous thromboembolism reaches a peak about three weeks after
surgery, but risks are substantially increased up to 12 weeks postoperatively
Risks are much greater after inpatient surgery than after day case surgery but are still
significantly elevated after day case surgery
Risks are greatest after joint replacement and surgery for cancer
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NICE guidelines9 suggest extended duration of drug
prophylaxis (that is, beyond hospital discharge) after
hip replacement and surgery for hip fracture only,
when it is recommended for up to four weeks. The
findings from this study suggest that there is a substan-
tially increased risk of venous thromboembolism after
many different types of surgery that lasts for up to
12 weeks postoperatively.
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